7:30 AM - 8:10 AM | Fisher Atrium, UCSF Mission Bay Conference Center

Registration opened for members at the UCSF Mission Bay Conference Center in San Francisco’s Mission Bay neighborhood. Members met with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings and more.

8:05 AM - 8:15 AM | Robertson Auditorium at UCSF Mission Bay Conference Center

Photo feature: Cavendish Global’s Managing Partner, Tom McKenzie, delivered opening remarks at the 2018 Chicago Forum.

8:15 AM - 8:45 AM | Moderated by Geoffrey T. Manley, MD, PhD, Vice Chairman and Professor in Residence, Neurological Surgery, UCSF; Co-Director and Principal Investigator, Brain and Spinal Injury Center (BASIC), UCSF; and Chief of Neurosurgery, Zuckerberg San Francisco General Hospital; featuring Garen Staglin, Philanthropist, Co-Founder and Board Chairman, One Mind; and Beth McQuiston, MD, RD, Medical Director, Abbott (Diagnostics)

Photo feature: Garen Staglin, Geoffrey T. Manley, MD, PhD, and Beth McQuiston, MD, RD

8:45 AM - 9:45 AM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, delivered impact presentations on their latest breakthrough work.

Photo feature: Michael Mullan, MBBS (MD), PhD, CEO and CSO, Archer Pharmaceuticals; one of the Innovation Partners that presented at the 2019 San Francisco Forum.

9:45 AM - 10:30 AM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center

Immediately following Innovation Partner impact presentations, members enjoyed a break to grab coffee, met one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of their presentations, in the exhibition space.

Meetings were set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.

10:30 AM - 11:00 AM | Robert C. Malenka, MD, PhD, Nancy Friend Pritzker Professor, Psychiatry and Behavioral Sciences, Stanford University; Director, Nancy Priztker Laboratory; and Deputy Director, Stanford Neurosciences Institute

11:00 AM - 11:30 AM | Featuring James Mulry, Head of Global Health Diagnostics, Merck Global Health Institute; together with Nuno Martins, Diagnostics Manager, Merck Global Health Institute.

The Global Health Institute was launched in April 2017 with the mission to develop transformative health solutions to support control and elimination programs related to infectious diseases carrying a major toll on children, and to contribute to the United Nations Sustainable Development Goals (SDGs).

11:30 AM - 12:00 PM | Sheri Sobrato Brisson, Trustee, The Sobrato Organization and Sobrato Philanthropies; Founder, The Digging Deep Project

Sheri Sobrato Brisson is founder of the Digging Deep Project, coauthor of the award-winning book, Digging Deep: A Journal for Young People Facing Health Challenges, and producer of Shadow's Edge, the first-ever mobile game for teens with medical conditions. Sheri is a founding trustee of the Sobrato Family Foundation, a foundation committed to improving the quality of life in California’s Silicon Valley.

12:00 PM - 1:15 PM | Fisher Atrium at UCSF Mission Bay

Cavendish members and speakers from around the San Francisco Bay Area dined together, over a casual buffet lunch at UCSF Mission Bay. Cavendish luncheons never feature keynote speakers, leaving attendees uninterrupted to network, meet and dine.

1:15 PM - 1:35 PM | Moderated by Rachel Butler, Executive Director, Cavendish Impact Foundation, together with Timothy Freundlich, CEO, ImpactAssets and Richard Lipkin, COO, Cavendish Impact Capital and Partner, Easton Capital

In the fifth installment of a continuing panel series on impact investing, the Cavendish Impact Foundation's Rachel Butler and Richard Lipkin joined philanthropic partner, ImpactAssets' CEO, Timothy Freundlich, to discuss the latest strategies in impact investment using philanthropic capital, and how to approach and participate in transactions from the standpoints of donors and innovators.

Photo feature: Peter McCrea and Timothy Freundlich

1:35 PM - 2:15 PM | Moderated by Peter Samuelson, Co-Founder and CEO, PhilmCo; together with Keisha Senter, CEO, The Solution Senter and former Vice President, Will and Jada Smith Family Foundation; Jonathan Prince, American Actor, director, movie producer, screenwriter; and Rob Densen, Founder and CEO, Tiller LLC.

PhimCo is a double bottom line media company that merges Philanthropy and Filmmaking into a unique model of development, financing, production, distribution and marketing of purposeful films, documentaries and other entertainment. With every project, PhilmCo partners with the stakeholders who have a passion for the very issues being tackled. PhilmCo moves ideas to action.

Photo feature (clockwise): Peter Samuelson, Keisha Senter, Rob Densen and Jonathan Prince

2:15 PM - 3:15 PM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, delivered impact presentations on their latest breakthrough work.

Photo feature: Mike Peck, President and CEO, Innara Health; one of the Innovation Partners that presented at the 2019 San Francisco Forum.

3:15 PM - 3:45 PM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center

Immediately following Innovation Partner impact presentations, members enjoyed a break to grab coffee, met one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of their presentations, in the exhibition space.

Meetings were set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.

3:45 PM - 4:15 PM | Featuring Karyn DiGiorgio, MSN, MS, RN, Chief Operating Officer, Quantum Leap Healthcare Collaborative; together with Laura J. van’t Veer, PhD, Leader, Breast Oncology Program, and Director, Applied Genomics, and Angela and Shu Kai Chan Endowed Chair in Cancer Research, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

A 501c(3) charitable organization, Quantum Leap Healthcare Collaborative was established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. Their mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients and researchers. QLHC’s goal is to improve and save lives.

The founders of QLHC recognize that good ideas and research projects in a University setting were often “orphaned” at the end of a research project. These efforts were frequently left with no funds or organizational structure to adequately engage clinical providers and ultimately benefit patient care. In addition, the intellectual property often created as part of these research endeavors remain untapped and undeveloped.

QLHC supports the development and implementation of innovative ways to deliver better, less costly healthcare. They are committed to establishing unique collaborations across the medical, technology and bioscience industries: all necessary components to accelerate healthcare research into the marketplace. Their efforts focus on quality-of-care and quality-of-life issues, and to create initiatives that foster excellent clinical practices using quality improvement disciplines with a strong patient-centric focus.

Photo feature: Karyn DiGiorgio, MSN, MS, RN and Laura J. Van’t Veer, PhD

4:15 PM - 4:45 PM | Featuring Christian Braemer, founder and CEO, Benefunder, together with Elizabeth Horn, Autism Parent and founder, COMPASS

Emerging technologies and a diversified funding strategy are the best chance we have ever had to find answers for autism. COMPASS co-founder and autism parent, Elizabeth Horn, founder of Benefunder, Christian Braemer, explained how.

Photo feature: Elizabeth Horn and Christian Braemer

4:45 PM - 5:15 PM | Featuring Laird Cagan, San Francisco Chair, TIGER 21, together with Lorine Pendleton, Esq., New York Chair, TIGER 21, and Board Advisor, Cavendish Impact Foundation

TIGER 21 (The Investment Group for Enhanced Results in the 21st Century) provides their Members with a close-knit network to discuss topics that matter most.

Their 600+ Members are from every industry, and collectively manage more than $50 billion in personal assets. TIGER 21’s mission is to help their Members improve their investment acumen, tackle common issues of wealth preservation, manage family-related challenges, and understand everything from estate planning options, to philanthropic endeavors.

Photo feature: Laird Cagan and Lorine Pendleton, Esq.

5:00 PM - 8:00 PM | Fisher Atrium at UCSF Mission Bay

General Session programming closed with the immediate opening of the Evening Cocktail Reception.

Cavendish and Forum partners delivered remarks, repeated the call for greater collaboration, innovation and impact, and highlighted the upcoming 2019 New York Forum in April - Cavendish’s 20th event!